Income Taxes - Schedule of Reconciliations of the Statutory Income Tax Rate and the Group’s Effective Income Tax (Details) - USD ($) |
6 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Schedule of Reconciliations of the Statutory Income Tax Rate and the Company’s Effective Income Tax Rate [Abstract] | ||
| Net loss before income tax expense from continuing operations | $ (3,669,056) | $ (912,941) |
| PRC statutory tax rate | 25.00% | 25.00% |
| Income tax at statutory tax rate | $ (917,264) | $ (228,235) |
| Effect of income tax rate differences in jurisdictions other than the PRC | 339,925 | 159,490 |
| Expenses not deductible for tax purpose and non-taxable income | 78,028 | 122,386 |
| Additional deduction of R&D expenses | (17,128) | (22,507) |
| Effect of preferential tax rates | 146,351 | (12,261) |
| Effect of utilization of tax loss carried forward | 68,133 | 2,461 |
| Effect on valuation allowance | 340,148 | |
| Income tax expense | $ 38,193 | $ 21,334 |
| X | ||||||||||
- Definition Represents the additional deduction of R&D expenses. No definition available.
|
| X | ||||||||||
- Definition Represent the amount of effect of preferential tax rates. No definition available.
|
| X | ||||||||||
- Definition Income tax at statutory tax rate. No definition available.
|
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|